Journal of Clinical Anesthesia
Volume 21, Issue 8 , Pages 567-573 , December 2009

Risk factors for the development of reversible psychomotor dysfunction following prolonged isoflurane inhalation in the general intensive care unit

  • Jun Ariyama (Associate Professor)

      Affiliations

    • Department of Anesthesiology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, Japan 350-1298
    • Corresponding Author InformationCorresponding author. Tel.: +81 42 984 4394; fax: +81 42 984 4394.
    • ,
  • Masakazu Hayashida (Professor)

      Affiliations

    • Department of Anesthesiology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, Japan 350-1298
    • ,
  • Keizo Shibata (Staff Anesthesiologist)

      Affiliations

    • Division of Anesthesia and Pain Clinic, Intensive Care Unit, Tonami General Hospital, 1-61 Shintomicho, Tonami, Toyama, Japan 939-1395
    • ,
  • Yuji Sugimoto (Staff Anesthesiologist)

      Affiliations

    • Division of Anesthesia and Pain Clinic, Intensive Care Unit, Tonami General Hospital, 1-61 Shintomicho, Tonami, Toyama, Japan 939-1395
    • ,
  • Hirokazu Imanishi (Staff Anesthesiologist)

      Affiliations

    • Department of Anesthesiology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, Japan 350-1298
    • ,
  • Yoshiyuki O-oi (Professor)

      Affiliations

    • Department of Anesthesiology, Nihon University, School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda, Tokyo, Japan 101-8310
    • ,
  • Akira Kitamura (Professor)

      Affiliations

    • Department of Anesthesiology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama, Japan 350-1298

Received 19 December 2007 ,Revised 7 January 2009 ,Accepted 8 January 2009.

References 

  1. Ostermann ME, Keenan SP, Seiferling RA, et al. Sedation in the intensive care unit. JAMA. 2000;283:1451–1459
  2. Spencer EM, Willatts SM. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med. 1992;18:415–421
  3. Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ. 1989;298:1277–1280
  4. Kong KL, Willatts SM, Prys-Roberts C, et al. Plasma catecholamine concentration during sedation in ventilated patients requiring intensive therapy. Intensive Care Med. 1990;16:171–174
  5. Tanigami H, Yahagi N, Kumon K, et al. Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artif Organs. 1997;21:21–23
  6. Sackey PV, Martling CR, Granath F, et al. Prolonged isoflurane sedation of intensive care unit patients with the anesthetic conserving device. Crit Care Med. 2004;32:2241–2246
  7. Sackey PV, Martling CR, Carlswärd C, et al. Short- and long-term follow-up of intensive care unit patients after sedation with isoflurane and midazolam–a pilot study. Crit Care Med. 2008;36:801–806
  8. Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med. 2006;32:927–933
  9. Kelsall AW, Ross-Russell R, Herrick MJ. Reversible neurologic dysfunction following isoflurane sedation in pediatric intensive care. Crit Care Med. 1994;22:1032–1034
  10. Arnold JH, Truog RD, Rice SA. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg. 1993;76:520–526
  11. McBeth C, Watkins TG. Isoflurane for sedation in a case of congenital myasthenia gravis. Br J Anaesth. 1996;77:672–674
  12. Hughes J, Leach HJ, Choonara I. Hallucinations on withdrawal of isoflurane used as sedation. Acta Paediatr. 1993;82:885–886
  13. Stevens JJ, Griffin RM, Stow PJ. Prolonged use of isoflurane in a patient with tetanus. Br J Anaesth. 1993;70:107–109
  14. Bergman I, Steeves M, Burckart G, Thompson A. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr. 1991;119:644–649
  15. Dominguez KD, Crowley MR, Coleman DM, et al. Withdrawal from lorazepam in critically ill children. Ann Pharmacother. 2006;40:1035–1039
  16. Katz R, Kelly HW, Hsi A. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med. 1994;22:763–767
  17. Road J, Mackie G, Jiang TX, et al. Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiological correlates. Muscle Nerve. 1997;20:1587–1590
  18. Chu NS. Caffeine- and aminophylline-induced seizures. Epilepsia. 1981;22:85–94
  19. Sponheim S, Skraastad O, Helseth E, et al. Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Anaesthesiol Scand. 2003;47:932–938
  20. Koerner IP, Brambrink AM. Brain protection by anesthetic agents. Curr Opin Anaesthesiol. 2006;19:481–486
  21. Eger EI, Stevens WC, Cromwell TH. The electroencephalogram in man anesthetized with forane. Anesthesiology. 1971;35:504–508
  22. Javtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat and persistent learning deficits. J Neurosci. 2003;23:876–882
  23. Soriano SG, Anand KJ. Anesthetics and brain toxicity. Curr Opin Anaesthesiol. 2005;18:293–297
  24. Mellon RD, Simone AF, Rappaport BA. Use of anesthetic agents in neonates and young children. Anesth Analg. 2007;104:509–520
  25. Pandharipand P, Cotton BA, Shintani A, et al. Motoric subtype of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med. 2007;33:1726–1731
  26. Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother. 2002;36:1453–1456

PII: S0952-8180(09)00278-5

doi: 10.1016/j.jclinane.2009.01.011

Journal of Clinical Anesthesia
Volume 21, Issue 8 , Pages 567-573 , December 2009

Article Tools